Medical Services Continues to Move Into Eastern Europe

May 25, 2005
Medical Services International Inc. (OTC: MSITF) wishes to announce that both its VScan HIV 1&2 test kits and its Tuberculosis (TB) test kit have been submitted for approval by regulatory authorities in the Ukraine. The necessary testing is being completed at this time. Medical Services has now applied for regulatory approval of its VScan test kits in 8 eastern European countries, The Company is in negotiation with distributors in all 8 countries. Current market studies show that there will be a significant demand for the VScan diagnostic test kits. It is reasonable to expect that the Company will supply in excess of 4,000,000 test kits into this region within a year. Both HIV and Tuberculosis are very prevalent in these countries.

 
About VScan ™

The VScan™ rapid test kit is a single use, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever and West Nile, Malaria, Syphilis, and Prostate Cancer. The kits cannot be sold in Canada.

For further information contact:
Robert Talbot at 780-430-6363 or
Bill Whitehead, Jr., 416-822-5883

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF".